Phase 2 Acute Lymphocytic Leukemia Refractory Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of CTD402 in T-ALL/LBL Patients

Lymphoma, LymphoblasticAcute Lymphocytic Leukemia Refractory

BIOHENG THERAPEUTICS US LLC54 enrolled8 locationsNCT07070219

Recruiting

Phase 1Phase 2

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

ALL, Childhood B-CellAcute Lymphoid Leukemia RelapseAcute Lymphocytic Leukemia Refractory

University Hospital Tuebingen20 enrolled11 locationsNCT05366218